These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8494246)

  • 41. 1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1997 Jan; 46(RR-2):1-29. PubMed ID: 9011774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Site Investigators and The NIAID DAIDS New Technologies Evaluation Group.
    Schnizlein-Bick CT; Spritzler J; Wilkening CL; Nicholson JK; O'Gorman MR
    Clin Diagn Lab Immunol; 2000 May; 7(3):336-43. PubMed ID: 10799443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. When laboratories go with flow analysis.
    Check W
    CAP Today; 1998 Nov; 12(11):1, 20, 26 passim. PubMed ID: 10339304
    [No Abstract]   [Full Text] [Related]  

  • 44. How many gated lymphocytes are needed for accurate assessment of T-subset percentages by flow cytometry?
    Lape'-Nixon ML; Prince HE
    Cytometry; 1996 Sep; 26(3):223-6. PubMed ID: 8889395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolution of leukocyte immunophenotyping as influenced by the HIV/AIDS pandemic: a short history of the development of gating strategies for CD4+ T-cell enumeration.
    Mandy FF; Bergeron M; Minkus T
    Cytometry; 1997 Aug; 30(4):157-65. PubMed ID: 9298833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD3+, CD56+ non-MHC restricted cytotoxic T lymphocytes in two fraternal AIDS patients: a case report.
    Warzynski MJ; Barbour SD; Winkler-Pickett RT; Ortaldo JR
    Cytometry; 1994 Dec; 18(4):231-6. PubMed ID: 7534677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glutathione and immunophenotypes of T and B lymphocytes in HIV-infected individuals.
    Staal FJ; Roederer M; Herzenberg LA; Herzenberg LA
    Ann N Y Acad Sci; 1992 May; 651():453-63. PubMed ID: 1376062
    [No Abstract]   [Full Text] [Related]  

  • 48. Report of the workshop on the evaluation of T-cell subsets during HIV infection and AIDS.
    Kidd PG; Vogt RF
    Clin Immunol Immunopathol; 1989 Jul; 52(1):3-9. PubMed ID: 2785889
    [No Abstract]   [Full Text] [Related]  

  • 49. CD4+ T-cell testing practices as implications for training.
    Rosner E; Willis V; Lambert R; Latzanich G; Ponsell P
    Cytometry; 1997 Aug; 30(4):181-5. PubMed ID: 9298836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. From the Centers for Disease Control. Availability of flow cytometric immunophenotyping of lymphocytes to hospital patients--United States.
    JAMA; 1992 Sep; 268(11):1395-6. PubMed ID: 1355118
    [No Abstract]   [Full Text] [Related]  

  • 51. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased expression of activation markers on CD8 lymphocytes in children with human immunodeficiency virus-1 infection.
    Schlesinger M; Peters V; Jiang JD; Roboz JP; Bekesi JG
    Pediatr Res; 1995 Sep; 38(3):390-6. PubMed ID: 7494665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS.
    Calvelli T; Denny TN; Paxton H; Gelman R; Kagan J
    Cytometry; 1993 Oct; 14(7):702-15. PubMed ID: 8243200
    [No Abstract]   [Full Text] [Related]  

  • 54. Capacity of US labs to provide TLI in support of early HIV-1 intervention.
    Valdiserri RO; Cross GD; Gerber AR; Schwartz RE; Hearn TL
    Am J Public Health; 1991 Apr; 81(4):491-4. PubMed ID: 2003631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First proposed panels on acute leukemia for four-color immunophenotyping by flow cytometry from the Brazilian group of flow cytometry-GBCFLUX.
    Ikoma MR; Sandes AF; Thiago LS; Cavalcanti Júnior GB; Lorand-Metze IG; Costa ES; Pimenta G; Santos-Silva MC; Bacal NS; Yamamoto M; Souto EX;
    Cytometry B Clin Cytom; 2015; 88(3):194-203. PubMed ID: 24753208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. More than just quality control.
    Carey JL; Oldaker TA
    Clin Lab Med; 2007 Sep; 27(3):687-707, ix. PubMed ID: 17658413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Storage as a factor in enumeration of CD4+ lymphocytes.
    Moll B
    J Infect Dis; 1992 Nov; 166(5):1198-9. PubMed ID: 1402038
    [No Abstract]   [Full Text] [Related]  

  • 58. A multicenter evaluation of the PanLeucogating method and the use of generic monoclonal antibody reagents for CD4 enumeration in HIV-infected patients in Thailand.
    Pattanapanyasat K; Shain H; Noulsri E; Lerdwana S; Thepthai C; Prasertsilpa V; Likanonsakul S; Yothipitak P; Nookhai S; Eksaengsri A
    Cytometry B Clin Cytom; 2005 May; 65(1):29-36. PubMed ID: 15800883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality Control of Immunophenotyping.
    Greig B
    Methods Mol Biol; 2019; 2032():227-279. PubMed ID: 31522423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential leukocyte counting and immunophenotyping in cryopreserved ex vivo whole blood.
    Nemes E; Kagina BM; Smit E; Africa H; Steyn M; Hanekom WA; Scriba TJ
    Cytometry A; 2015 Feb; 87(2):157-65. PubMed ID: 25515205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.